Tag: generic drugs
How Generic Drugs Are Reshaping the Economics of Brand Pharmaceutical Companies
Generic drugs save the U.S. healthcare system over $300 billion a year-but they're also forcing brand manufacturers to rethink their entire business model. Here's how patent expirations, pricing wars, and corporate strategies are reshaping the pharmaceutical industry.
FDA Regulatory Authority: How the Agency Approves Generic Drugs
The FDA approves generic drugs through the ANDA process, ensuring they are bioequivalent to brand-name drugs without repeating clinical trials. This system saves billions annually and makes medications affordable for millions.
Future Role of Authorized Generics: Market Outlook
Authorized generics are brand-name drugs sold under a generic label. As patents expire on high-revenue drugs, their role in pricing and competition is shifting - with new FDA policies and domestic manufacturing incentives changing how they’re used.